Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees (Q35903591)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees |
scientific article published in February 2004 |
Statements
1 reference
Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees (English)
1 reference
Anders Anell
1 reference
1 February 2004
1 reference
1 reference
5
1 reference
1
1 reference
28-35
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference